24.24
0.96 (4.12%)
| Previous Close | 23.28 |
| Open | 23.30 |
| Volume | 220,716 |
| Avg. Volume (3M) | 166,950 |
| Market Cap | 632,901,248 |
| Price / Sales | 2.19 |
| Price / Book | 1.77 |
| 52 Weeks Range | |
| Earnings Date | 28 Oct 2026 |
| Profit Margin | -19.15% |
| Operating Margin (TTM) | -20.87% |
| Diluted EPS (TTM) | -1.76 |
| Quarterly Revenue Growth (YOY) | 17.30% |
| Total Debt/Equity (MRQ) | 23.01% |
| Current Ratio (MRQ) | 6.19 |
| Operating Cash Flow (TTM) | -24.51 M |
| Levered Free Cash Flow (TTM) | -24.69 M |
| Return on Assets (TTM) | -4.23% |
| Return on Equity (TTM) | -11.34% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | OrthoPediatrics Corp. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 0.50 |
|
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 33.09% |
| % Held by Institutions | 71.12% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |